Derivation Web

claim_a6f31dd0bf4943ba

# Research Synthesis: Liraglutide Biomarker Effects — full paper

## Abstract

Evidence-honesty note: 43/56 retained sources are indirect, review-level, adjacent, or mechanistic and are used only to bound interpretation. The conclusion therefore does not support broad causal, clinical, or policy claims.

Liraglutide, a glucagon-like peptide-1 receptor agonist, is now evaluated across an unusually …

source_52ba4b5f7ea0417b

# Research Synthesis: Liraglutide Biomarker Effects — full paper

## Abstract

Evidence-honesty note: 43/56 retained sources are indirect, review-level, adjacent, or mechanistic and are used only to bound interpretation. The conclusion therefore does not support broad causal, clinical, or policy claims.

Liraglutide, a glucagon-like peptide-1 receptor agonist, is now evaluated across an unusually …

source_d336161e46d440f8

{"publication_id": "d8f38608-04e9-4baf-a98a-b15cef29f955", "traces": [{"candidate_sources": [{"directness": "review-level", "doi": "10.1186/s12902-024-01805-z", "effect": "not extracted", "endpoint": "not extracted", "population": "not extracted", "source_id": "source_1", "study": "Evaluation and comparison of efficacy and safety of tirzepatide, liraglutide and SGLT2i in patients with type 2 diabe…

source_f49bb7011b2447e9

{"content_hash": "sha256:8d5802dcfe9b263a6194cab28126ef484ac8a8682cdcba92653d0f4a50e195e0", "edges": [{"from": "d8f38608-04e9-4baf-a98a-b15cef29f955", "to": "claim_1", "type": "contains_claim"}, {"from": "d8f38608-04e9-4baf-a98a-b15cef29f955", "to": "claim_2", "type": "contains_claim"}, {"from": "d8f38608-04e9-4baf-a98a-b15cef29f955", "to": "claim_3", "type": "contains_claim"}, {"from": "d8f38608-…

source_2eab82fb024a4aed

{"contradictions": ["The corpus contains 13 direct clinical sources, 42 adjacent, review, or context sources, and 1 mechanistic or model-system source. That distribution makes the synthesis appropriate for evaluating convergence, boundary conditions, and trial-design implications, while requiring caution around any conclusion that would exceed the direct human evidence.", "Null findings have a spe…

source_67bac67f85494127

study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness
"Evaluation and comparison of efficacy and safety of tirzepatide, liraglutide and SGLT2i in patients with type 2 diabetes mellitus: a network meta-analysis",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level
A randomized trial to investigate…

source_7c6f6486e39d4113

{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "d8f38608-04e9-4baf-a98a-b15cef29f955", "sources": [{"directness": "review-level", "doi": "10.1186/s12902-024-01805-z", "risk_of_bias": "not appraised in public sidecar", "study": "Evaluation and comparison of efficacy and safety of tirze…

source_89a5bc6565ce4249

{"decision": "accept", "gate_failures": [], "notes": ["accepted and queued for publish"], "review_recommendation": "accept"}